Dhruvitkumar S. Sutaria, PhD

Genentech, Inc.

Dr. Dhruvitkumar (Dhruvit) Sutaria, PhD is currently a Scientist within the Clinical Pharmacology department at Genentech Inc. where he supports clinical drug development of small and large molecules for oncology. Prior to joining Genentech, he was a postdoctoral associate at Center for Pharmacometrics and Systems Pharmacology at University of Florida and obtained his PhD in pharmaceutics and pharmaceutical chemistry from Ohio State University at Columbus, OH. He has been a active member of ASCPT since 2016 and has served on the Infectious Disease Steering committee in addition to being an abstract/scientific proposal reviewer.

Poster(s):

• P-173 - EVALUATION OF MORNING VERSUS EVENING DOSING OF IPATASERTIB, AN AKT INHIBITOR TO MITIGATE IPATASERTIB INDUCED GLUCOSE CHANGES.